Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-08-20), EnBio Holdings's 14-Day RSI is 72.39.
The industry rank for EnBio Holdings's 14-Day RSI or its related term are showing as below:
TSE:6092's 14-Day RSI is ranked worse than 93.68% of 1124
companies
in the Business Services industry
Industry Median: 49.58
vs TSE:6092: 72.39
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
EnBio Holdings 14-Day RSI Related Terms
TSE:6092 vs CTAS, CPRT, GPN: 14-Day RSI Comparison
For the Specialty Business Services subindustry, EnBio Holdings's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings 14-Day RSI vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings (TSE:6092) has a 14-Day RSI of 72.39 as of Aug. 20, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on EnBio Holdings and its competitors. According to the industry distribution chart, EnBio Holdings ranks #1053 out of 1124 companies in the Business Services industry, placing it in the top 93.7%.
Is EnBio Holdings' 14-Day RSI too high?
EnBio Holdings' current 14-Day RSI is 72.39. The Business Services industry median 14-Day RSI is 49.58. EnBio Holdings' value of 72.39 is 46% above this industry median. Based on the distribution chart, EnBio Holdings ranks #1053 out of 1124 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' 14-Day RSI compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #1053 out of 1124 companies for 14-Day RSI. This places EnBio Holdings in the lower half of its industry. The industry median 14-Day RSI is 49.58. EnBio Holdings' value of 72.39 is 46% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Business Services company?
The median 14-Day RSI among Business Services companies is 49.58, based on 1,124 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current 14-Day RSI of 72.39 is 46% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median 14-Day RSI is 49.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current 14-Day RSI is 72.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円805.55, compared to a current price of 円864.00 — trading 7.3% above its estimated fair value. The current 14-Day RSI is 72.39 and 46% above the Business Services industry median of 49.58. EnBio Holdings' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current 14-Day RSI is 72.39 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be overvalued.
The current stock price of 円864.00 is trading 7.3% above its estimated GF Value™ of 円805.55.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
14-Day RSI: 72.39
GF Value™: 円805.55 vs. price of 円864.00 (7.3% above fair value)
Industry Position: 46% above the Business Services median (#1053 of 1124)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
